APA (7th ed.) Citation

CC, Z., HL, S., TF, L., YY, L., JL, L., & GT, N. (2024). ZNF554 Inhibits Endometrial Cancer Progression via Regulating RBM5 and Inactivating WNT/β-Catenin Signaling Pathway. Current medical science, 44(2), 406. https://doi.org/10.1007/s11596-024-2845-7

Chicago Style (17th ed.) Citation

CC, Zhu, Sun HL, Long TF, Lyu YY, Liu JL, and Ni GT. "ZNF554 Inhibits Endometrial Cancer Progression via Regulating RBM5 and Inactivating WNT/β-Catenin Signaling Pathway." Current Medical Science 44, no. 2 (2024): 406. https://doi.org/10.1007/s11596-024-2845-7.

MLA (9th ed.) Citation

CC, Zhu, et al. "ZNF554 Inhibits Endometrial Cancer Progression via Regulating RBM5 and Inactivating WNT/β-Catenin Signaling Pathway." Current Medical Science, vol. 44, no. 2, 2024, p. 406, https://doi.org/10.1007/s11596-024-2845-7.